EP Patent

EP0434385A2 — Use of macrocyclic nitrogen containing compounds for the treatment of retroviral infections

Assigned to Anormed Inc · Expires 1991-06-26 · 35y expired

What this patent protects

Pharmaceutical compositions containing as active ingredients a linked cyclic compound of the general formula I         Z - (A) n - Y (I) in which Z and Y are independently polyheterocyclic moieties having from 9 to 32 ring members and from 3 to 8 amine heteroatoms,…

USPTO Abstract

Pharmaceutical compositions containing as active ingredients a linked cyclic compound of the general formula I         Z - (A) n - Y (I) in which Z and Y are independently polyheterocyclic moieties having from 9 to 32 ring members and from 3 to 8 amine heteroatoms, especially nitrogen, in the ring, A is a linking atom or group, and n is 0 or an integer from 1 to 6, are indicated for the treatment of viral infections, and preventative administration, especially for retroviral infections.

Drugs covered by this patent

Patent Metadata

Patent number
EP0434385A2
Jurisdiction
EP
Classification
—
Expires
1991-06-26
Drug substance claim
No
Drug product claim
No
Assignee
Anormed Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.